Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY - Stock options activity (Details)

v3.24.2.u1
STOCKHOLDERS' EQUITY - Stock options activity (Details)
6 Months Ended
Jun. 30, 2024
$ / shares
shares
Shares  
Granted | shares 644,550
Ending balance | shares 644,550
Nonvested at June 30, 2024 | shares 644,550
Weighted average Exercise price per share  
Granted | $ / shares $ 7.02
Ending balance | $ / shares 7.02
Nonvested at June 30, 2024 | $ / shares $ 7.02
Weighted Average Remaining Contractual Life (Years)  
Outstanding June 30 10 years
Granted 10 years
Nonvested at June 30, 2024 10 years